Search research articles
Contact Us
Filters
Showing results (1-10 of 60) with videos related to
Page
of 6
Sort By:
Nature Biomedical Engineering
|
January 22, 2022
Chemomechanically antifibrotic stromal cells
Michael V Schrodt, James A Ankrum
Nature Biomedical Engineering
|
April 5, 2019
Manufacturing of primed mesenchymal stromal cells for therapy
James Q Yin, Jun Zhu, James A Ankrum
Frontiers in Immunology
|
March 6, 2020
Editorial: Safety, Efficacy and Mechanisms of Action of Mesenchymal Stem Cell Therapies
Guido Moll, Martin J Hoogduijn, James A Ankrum
Nature Biotechnology
|
February 25, 2014
Mesenchymal stem cells: immune evasive, not immune privileged
James A Ankrum, Joon Faii Ong, Jeffrey M Karp
Stem Cells International
|
October 6, 2016
Targeted Strategies to Modulate Stem-Cell-Relevant Pathways
Jonathan W Lowery, James A Ankrum, Shoichiro Kokabu, et al.
Advances in Wound Care
|
December 28, 2017
A Low-Cost Technique for Intraoperative Imaging of Cell Delivery and Retention in a Model of Delayed Wound Healing
Anthony J Burand, Lauren Boland, Alex J Brown, et al.
Stem Cells Translational Medicine
|
May 31, 2022
Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products
Guido Moll, James A Ankrum, Scott D Olson, et al.
Stem Cells (Dayton, Ohio)
|
October 21, 2016
Function of Cryopreserved Mesenchymal Stromal Cells With and Without Interferon-γ Prelicensing is Context Dependent
Anthony J Burand, Oliver W Gramlich, Alex J Brown, et al.
Frontiers in Immunology
|
July 21, 2022
Translating MSC Therapy in the Age of Obesity
Lauren Boland, Laura Melanie Bitterlich, Andrew E Hogan, et al.
Stem Cell Research & Therapy
|
August 7, 2025
Palmitate enhances MSC immunomodulation of human macrophages via the ceramide/CCL2 axis in vitro
Courteney Tunstead, Laura M Bitterlich, James A Ankrum, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 60) with videos related to
Sort By:
Page
of 6
Nature Biomedical Engineering
|
January 22, 2022
Chemomechanically antifibrotic stromal cells
Michael V Schrodt, James A Ankrum
Nature Biomedical Engineering
|
April 5, 2019
Manufacturing of primed mesenchymal stromal cells for therapy
James Q Yin, Jun Zhu, James A Ankrum
Frontiers in Immunology
|
March 6, 2020
Editorial: Safety, Efficacy and Mechanisms of Action of Mesenchymal Stem Cell Therapies
Guido Moll, Martin J Hoogduijn, James A Ankrum
Nature Biotechnology
|
February 25, 2014
Mesenchymal stem cells: immune evasive, not immune privileged
James A Ankrum, Joon Faii Ong, Jeffrey M Karp
Stem Cells International
|
October 6, 2016
Targeted Strategies to Modulate Stem-Cell-Relevant Pathways
Jonathan W Lowery, James A Ankrum, Shoichiro Kokabu, et al.
Advances in Wound Care
|
December 28, 2017
A Low-Cost Technique for Intraoperative Imaging of Cell Delivery and Retention in a Model of Delayed Wound Healing
Anthony J Burand, Lauren Boland, Alex J Brown, et al.
Stem Cells Translational Medicine
|
May 31, 2022
Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products
Guido Moll, James A Ankrum, Scott D Olson, et al.
Stem Cells (Dayton, Ohio)
|
October 21, 2016
Function of Cryopreserved Mesenchymal Stromal Cells With and Without Interferon-γ Prelicensing is Context Dependent
Anthony J Burand, Oliver W Gramlich, Alex J Brown, et al.
Frontiers in Immunology
|
July 21, 2022
Translating MSC Therapy in the Age of Obesity
Lauren Boland, Laura Melanie Bitterlich, Andrew E Hogan, et al.
Stem Cell Research & Therapy
|
August 7, 2025
Palmitate enhances MSC immunomodulation of human macrophages via the ceramide/CCL2 axis in vitro
Courteney Tunstead, Laura M Bitterlich, James A Ankrum, et al.
Page
of 6